Skip to main content
Log in

Monotherapy and polytherapy for intractable epilepsies

  • Original Articles
  • Published:
The Italian Journal of Neurological Sciences Aims and scope Submit manuscript

Abstract

A retrospective survey on 66 adults with epilepsy who received multiple drug therapy after the failure of single drugs showed: a reduction of seizure frequency of 75% or more in 16.5%, no change in 67% and an increase in seizure frequency of 100% or more in 16.5%. Multiple drug therapy is of limited value in severe epilepsies.

Sommario

Lo studio comprende una analisi retrospettica su 66 pazienti adulti con epilessia che, dopo non aver ottenuto la scomparsa completa delle crisi con differenti monoterapie, hanno intrapreso un trattamento combinato. Nel 16,5% dei casi si è osservata, con l'introduzione della politerapia, una riduzione delle crisi del 75% ed oltre; nel 67% non si è assistito ad alcuna modificazione della frequenza critica, mentre questa è aumentata del 100% ed oltre in un altro 16,5% dei casi. La politerapia sembra essere di valore limitato nei casi di epilessia farmaco-resistente.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. McGee J.:Rapid identification and quantitative determination of barbiturates and gluthetimide in blood by gas-liquid chromatography. Clin. Chem., 17:587–591, 1971.

    PubMed  Google Scholar 

  2. Reynolds E.H., Shorvon S.D.:Monotherapy or polytherapy for epilepsy?. Epilepsia, 22:1–10, 1974

    Google Scholar 

  3. Reynolds E.H., Chadwick D., Galbraith A.W.:One drug (Phenytoin) in the treatment of epilepsy. Lancet, 1:923–926, 1976

    PubMed  Google Scholar 

  4. Schmidt D.:Behandlung der Epilepsien. Georg Thieme Verlag, Stuttgart, 1981

    Google Scholar 

  5. Schmidt D.:Two antiepileptic drugs for intractable epilepsy with complex partial seizures. J. Neurol. Neurosurg. Psychiatry, 45:1119–1124, 1982

    PubMed  Google Scholar 

  6. Sherwin A.L., Harvey C.D., Leppik I.E.:Quantitation of antiepileptic drugs in human brain. In: P. Kellaway, I. Petersen (Eds.), Quantitative analytic studies in epilepsy, Raven Press, New York, pp 171–182, 1976.

    Google Scholar 

  7. Shorvon, S.D., Reynolds E.H.:Unnecessary polypharmacy for epilepsy. Brit. Med. J., 1:1635–1637, 1977

    PubMed  Google Scholar 

  8. Shorvon S.D., Reynolds, E.H.:Reduction in polypharmacy for epilepsy. Brit. Med. J., 2:1023–1025, 1979

    PubMed  Google Scholar 

  9. Shorvon S.D., Galbraith A.W., Laundy M., Vydelingum L., Reynolds E.H.:Monotherapy for epilepsy. In: S.J. Johannessen et al., (Eds.) Antiepileptic therapy: advances in drug monitoring, Raven Press, New York, pp 213–218, 1980.

    Google Scholar 

  10. Van Gelder N.M., Sherwin A.L., Rasmussen T.:Amino acid content of epileptogenic human brain focal versus surrounding regions. Brain Res., 40:385–393, 1972.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cornaggia, C., Canevini, M.P., Giuccioli, D. et al. Monotherapy and polytherapy for intractable epilepsies. Ital J Neuro Sci 6, 201–205 (1985). https://doi.org/10.1007/BF02229193

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02229193

Key-Words

Navigation